Cerivastatin sodium
Cerivastatin sodium is a highly potent, orally active inhibitor of HMG-CoA reductase, demonstrating lipid-lowering effects by reducing LDL cholesterol. It is utilized in research on hyperlipidemia and has been investigated in vitro and in vivo for its potential anticancer properties.
Product Specifications
CAS Number
143201-11-0
Product Name Alternative
HMGCoA Reductase, HMG-CoA Reductase, HMG-CoA reductase, HMGCoAReductase, Ferroptosis, NOP receptor, OpioidReceptor, Opioid Receptor, Cerivastatin sodium, BAY W 6228 sodium
Field of Research
Cell Biology, Metabolism Research, Neuroscience, Pharmacology & Drug Discovery
Purity
98.50% (May vary between batches)
Solubility
DMSO:80 mg/mL (166.14 mM) ; H2O:80 mg/mL (166.14 mM)
Smiles
[O-]C (C[C@H] (O) C[C@H] (O) /C=C/C1=C (C (C) C) N=C (C (C) C) C (COC) =C1C2=CC=C (C=C2) F) =O.[Na+]
Molecular Formula
C26H33FNNaO5
Molecular Weight
481.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
223620-01 50 µL
IMPDH2 (IMDH2_HUMAN, IMP (inosine Monophosphate) Dehydrogenase 2, IMP Dehydrogenase 2, IMP oxireductase 2, IMPD 2, IMPD2, IMPDH 2, IMPDH II, IMPDH-II, Impdh2, Inosine Monophosphate Dehydrogenase Type II, ) discontinued
Sign In for Pricing
View Details 223620-02 100 µL
IMPDH2 (IMDH2_HUMAN, IMP (inosine Monophosphate) Dehydrogenase 2, IMP Dehydrogenase 2, IMP oxireductase 2, IMPD 2, IMPD2, IMPDH 2, IMPDH II, IMPDH-II, Impdh2, Inosine Monophosphate Dehydrogenase Type II, ) discontinued
Sign In for Pricing
View Details 